Technetium (99mTc) medronic acid

Technetium (99mTc) medronic acid
Clinical data
Trade namesMdp-Bracco
License data
Routes of
administration
Intravenous
ATC code
Legal status
Legal status
Identifiers
  • Methylenebis(phosphonic acid) technetium (99mTc)
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaCH6O6P2 • x99mTc
Molar mass unknown
  (verify)

Technetium (99mTc) medronic acid is a pharmaceutical product used in nuclear medicine to localize bone metastases[1] as well as other diseases that can alter the natural turn-over in the bone by bone scintigraphy.[2]

  1. ^ Uematsu T, Yuen S, Yukisawa S, Aramaki T, Morimoto N, Endo M, et al. (April 2005). "Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer". AJR. American Journal of Roentgenology. 184 (4): 1266–73. doi:10.2214/ajr.184.4.01841266. PMID 15788608.
  2. ^ FDA Label: MDP Multidose Utilipack